MDGL stock · PEG stock

MDGL vs PEG · rev $180.1M vs P/E 18, rev $10.29B

Madrigal Pharmaceuticals Inc (MDGL) versus Public Service Enterprise Group Inc (PEG) — a side-by-side from cached financials, not a winner call.

Madrigal Pharmaceuticals Inc (MDGL) is a biotechnology company listed on NASDAQ.

Public Service Enterprise Group Inc (PEG) is a utilities - regulated electric company listed on NYSE.

Latest reported MDGL revenue for 2024-12-31 was $180.1M. Net income was -$465.9M. MDGL currently screens at market cap $11.56B.

Latest reported PEG revenue for 2024-12-31 was $10.29B. Net income was $1.77B. Revenue was down 8.4% from 2023-12-31 to 2024-12-31. PEG currently screens at market cap $39.57B and trailing P/E 17.6.

MDGL currently screens at market cap $11.56B. PEG currently screens at market cap $39.57B and trailing P/E 17.6.

Not investment advice. Open the MDGL and PEG stock pages for the full models.

Not investment advice.

Popular Stock Comparisons